Authors: FRIEDMAN EA DISTANT DA FLEISHHACKER JF BOYD TA CARTWRIGHT K

Citation: Ea. Friedman et al., AMINOGUANIDINE PROLONGS SURVIVAL IN AZOTEMIC-INDUCED DIABETIC RATS, American journal of kidney diseases, 30(2), 1997, pp. 253-259

Authors: ERNHART CB GREENE T SOKOL RJ MARTIER S BOYD TA AGER J

Citation: Cb. Ernhart et al., NEONATAL DIAGNOSIS OF FETAL ALCOHOL SYNDROME - NOT NECESSARILY A HOPELESS PROGNOSIS, Alcoholism, clinical and experimental research, 19(6), 1995, pp. 1550-1557

Authors: HOOPER SR BOYD TA HYND GW RUBIN J

Citation: Sr. Hooper et al., DEFINITIONAL ISSUES AND NEUROBIOLOGICAL FOUNDATIONS OF SELECTED SEVERE NEURODEVELOPMENTAL DISORDERS, Archives of clinical neuropsychology, 8(4), 1993, pp. 279-307

Authors: BOYD TA HOOPER SR

Citation: Ta. Boyd et Sr. Hooper, WISC-R IQ ESTIMATES FROM THE LURIA-NEBRASKA NEUROPSYCHOLOGICAL BATTERY, Perceptual and motor skills, 77(2), 1993, pp. 683-688

Authors: MALLON VM ULRICH PC BOYD TA MIYAUCHI Y TAKASU T YAMIN MA

Citation: Vm. Mallon et al., N-[2-(4-MORPHOLINO)ETHYL]-N'-AMINOGUANIDINE (MEAG) INHIBITS AGE FORMATION INVITRO AND DIABETIC CHANGES IN STZ-DIABETIC RATS WITHOUT INHIBITING DIAMINE OXIDASE (DAO) OR NITRIC-OXIDE SYNTHASE (NOS), Diabetes, 42, 1993, pp. 106-106